Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
Kahn Brothers Group Portfolio 13F
Kahn Brothers Group Holdings Activity
- Portfolio value:
- $674.36M≈ (+$40M≈)
- Previous value:
- $634.76M≈
- # of changes:
- 49
- New positions:
- 13
- Reported for:
- 31 Mar 2024 (Q1)
- Latest filing date:
- 15 May 2024
Kahn Brothers Group has disclosed a total of 49 changes to the portfolio in the (2024 Q1) SEC report(s): increased the number of shares of 6, bought 13 totally new, decreased the number of shares of 27 and completely sold out 3 position(s).
What stocks did Kahn Brothers Group buy in 2024 Q1?
During 2024 Q1 Kahn Brothers Group has bought 19 securities out of which top 5 purchases (by % change to portfolio) were (MBI) MBIA Inc (added shares +7.18%), (SEB) Seaboard Corp (added shares +0.99%), (BAYRY) Bayer AG PK (added shares +334.97%), (OGN) Organon & Co (added shares +3,242.41%) and (FLG) Flagstar Financial, Inc (added shares +0.86%).
In the 2024 Q1 report(s) the following changes have been made to the top investments: (AGO) ASSURED GUARANTY LTD (reduced shares -1.70%), (MRK) Merck & Company Inc (reduced shares -1.72%), (C) Citigroup Inc (reduced shares -0.82%), (BP) BP PLC-SPONS ADR (reduced shares -2.81%) and (GSK) GlaxoSmithKline PLC ADR (reduced shares -0.46%).
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.